WO1996017927A3 - Reporter cell line - Google Patents
Reporter cell line Download PDFInfo
- Publication number
- WO1996017927A3 WO1996017927A3 PCT/EP1995/004819 EP9504819W WO9617927A3 WO 1996017927 A3 WO1996017927 A3 WO 1996017927A3 EP 9504819 W EP9504819 W EP 9504819W WO 9617927 A3 WO9617927 A3 WO 9617927A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nfλb
- expression
- cell line
- gene
- gene product
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 108700008625 Reporter Genes Proteins 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000001404 mediated effect Effects 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 108010018242 Transcription Factor AP-1 Proteins 0.000 abstract 1
- 102100023118 Transcription factor JunD Human genes 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention provides a cell line including a first reporter gene arranged to express an assayable first gene product, expression of the first reporter gene being AP-1 mediated, and a second reporter gene arranged to express a second assayable gene product, expression of the second reporter gene being mediated by NFλB. Thus the present invention provides a convenient one cell line-based assay system which can be used to rapidly test a large number of compounds for potential anti-inflammatory activity. According to a further aspect of the invention there is provided a method of testing a compound for both AP1 and NFλB inhibitory activity, the method comprising providing cells in accordance with the first aspect of the invention, stimulating AP1 and NFλB activity in the cells and contacting the cells with the compound to be tested and monitoring expression of the first and second gene products wherein inhibition of AP1 expression of the first gene product, and inhibition of NFλB mediated expression of the second gene product is indicative that the compound has both AP1 and NFλB-inhibitory activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU47134/96A AU4713496A (en) | 1994-12-05 | 1995-12-05 | Reporter cell line |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9424497A GB9424497D0 (en) | 1994-12-05 | 1994-12-05 | Reporter cell line |
GB9424497.7 | 1994-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996017927A2 WO1996017927A2 (en) | 1996-06-13 |
WO1996017927A3 true WO1996017927A3 (en) | 1996-08-29 |
Family
ID=10765423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1995/004819 WO1996017927A2 (en) | 1994-12-05 | 1995-12-05 | Reporter cell line |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4713496A (en) |
GB (1) | GB9424497D0 (en) |
WO (1) | WO1996017927A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1157126A4 (en) * | 1999-02-24 | 2005-03-02 | Gen Hospital Corp | Method for cloning signal transduction intermediates |
WO2003048202A2 (en) * | 2001-12-03 | 2003-06-12 | Asahi Kasei Pharma Corporation | Nf-kappab activating genes |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992007072A1 (en) * | 1990-10-10 | 1992-04-30 | La Jolla Cancer Research Foundation | Method of inhibiting transcription utilizing nuclear receptors |
WO1994017208A1 (en) * | 1993-01-21 | 1994-08-04 | President And Fellows Of Harvard College | Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
DE4311835A1 (en) * | 1993-04-07 | 1994-10-13 | Boehringer Ingelheim Int | Method for inhibiting gene transcription |
WO1995006754A1 (en) * | 1993-09-01 | 1995-03-09 | The Regents Of The University Of California | Methods for screening antiestrogen compounds |
WO1995031722A1 (en) * | 1994-05-18 | 1995-11-23 | Ligand Pharmaceuticals, Inc. | Screening for cytokine modulators |
-
1994
- 1994-12-05 GB GB9424497A patent/GB9424497D0/en active Pending
-
1995
- 1995-12-05 WO PCT/EP1995/004819 patent/WO1996017927A2/en active Application Filing
- 1995-12-05 AU AU47134/96A patent/AU4713496A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992007072A1 (en) * | 1990-10-10 | 1992-04-30 | La Jolla Cancer Research Foundation | Method of inhibiting transcription utilizing nuclear receptors |
WO1994017208A1 (en) * | 1993-01-21 | 1994-08-04 | President And Fellows Of Harvard College | Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
DE4311835A1 (en) * | 1993-04-07 | 1994-10-13 | Boehringer Ingelheim Int | Method for inhibiting gene transcription |
WO1995006754A1 (en) * | 1993-09-01 | 1995-03-09 | The Regents Of The University Of California | Methods for screening antiestrogen compounds |
WO1995031722A1 (en) * | 1994-05-18 | 1995-11-23 | Ligand Pharmaceuticals, Inc. | Screening for cytokine modulators |
Non-Patent Citations (3)
Title |
---|
A. RAY AND K.E. PREFONTAINE: "Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappaB and the glucocorticoid receptor", PROC. NATL.ACAD SCI., vol. 91, January 1994 (1994-01-01), NATL. ACAD SCI.,WASHINGTON,DC,US;, pages 752 - 756, XP002004799 * |
ALAM J ET AL: "REPORTER GENES: APPLICATION TO THA STUDY OF MAMMALIAN GENE TRANSCRIPTION", ANALYTICAL BIOCHEMISTRY, vol. 188, no. 2, 1 August 1990 (1990-08-01), pages 245 - 254, XP000563914 * |
C. JONAT ET AL.: "Antitumor promotion and antiinflammation: Down-modulation of AP-1(Fos/Jun) activity by glucocorticoid hormone", CELL, vol. 62, 21 September 1990 (1990-09-21), CELL PRESS,CAMBRIDGE,MA,US;, pages 1189 - 1204, XP002004798 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996017927A2 (en) | 1996-06-13 |
GB9424497D0 (en) | 1995-01-25 |
AU4713496A (en) | 1996-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE260989T1 (en) | INSIGHTS FROM GENOME RESEARCH FOR THE SEARCH FOR NOVEL ACTIVE INGREDIENTS | |
WO1999039001A3 (en) | Nucleic acid analysis method | |
EP0133671A3 (en) | Detection of bacteria by nucleic acid hybridization, labeled probes and test kit therefore | |
AU6837287A (en) | Amplified hybridization assay | |
CA2202154A1 (en) | Methods for drug screening | |
CA2152498A1 (en) | Method, test article, and system for performing assays | |
ATE79474T1 (en) | METHODS FOR IN VITRO DETECTION AND DETERMINATION OF UNKNOWN PATHOGENS OR GENETIC UNITS. | |
EP0370719A3 (en) | Extended nucleotide sequences | |
EP0874913A4 (en) | Multiple reporter gene assay | |
AU7222698A (en) | Method of preparing a standard diagnostic gene transcript pattern | |
HK1096151A1 (en) | Devices and methods relating to electrochemical biosensors | |
IL71715A0 (en) | Method,gene probes and test kit for detecting bacteria by nucleic acid hybridization | |
AUPQ422399A0 (en) | Method of screening transformed or transfected cells | |
ES8900235A1 (en) | Method for performing nucleic acid hybridization assays. | |
FI953990A (en) | A method of rendering a nucleic acid amplification reaction product incapable of further amplification, a diagnostic assay method using this method, and a test kit and container suitable for performing the method or assay. | |
WO1993020230A1 (en) | Electrochemical detection of dna hybridisation | |
BR9810844A (en) | Process for detecting a microorganism in a test liquid sample, and an assay device for conducting the process | |
DE69937689D1 (en) | STABILIZED TRANSFECTED CELLS FOR THE FINDING OF ACTIVE INGREDIENTS INFLUENCING MRNA STABILITY | |
AUPO128096A0 (en) | Biosensors | |
WO1991014003A3 (en) | Characterization and analysis of polymorphic vntr loci | |
Ulrich | Conservation of DNA damage tolerance pathways from yeast to humans | |
WO1998007844A3 (en) | Screening assay for the identification of agents which alter expression of pth-rp | |
WO1996017927A3 (en) | Reporter cell line | |
EP0787805A3 (en) | Probe compositions for chromosome identification and method | |
WO2000058521A3 (en) | Methods for the identification of reporter and target molecules using comprehensive gene expression profiles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |